Comparison

Ensitrelvir (S-217622)

Item no. DCC-DC59016-250mg
Manufacturer DCChemicals
CASRN 2647530-73-0
Amount 250 mg
Quantity options 100 mg 10 mM x 1 ml in DMSO 1 g 250 mg
Category
Type Chemicals
Applications S-217622 is the first oral non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor with IC50 of 0.096 μM. S-217622 displays antiviral activity in vitro towards a range of SARS-CoV-2 variants and coronavirus families, favorable drug metabolism and pharmacokinetic (DMPK) profiles.
Specific against other
Smiles C1(=O)N/C(=N\C2=CC3C(C=C2Cl)=NN(C)C=3)/N(CC2=C(C=C(C(=C2)F)F)F)C(N1CC1=NN(C)C=N1)=O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Manufacturer - Applications
S-217622 is the first oral non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor with IC50 of 0.096 μM. S-217622 displays antiviral activity in vitro towards a range of SARS-CoV-2 variants and coronavirus families, favorable drug metabolism and pha
Molecular Weight
531, 884

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close